You have 9 free searches left this month | for more free features.

Condition

Colorectal Cancer (1)

Metastatic Colorectal Cancer (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Hoffmann-La Roche (2)

Collaborator

Intervention

cibisatamab (2)

obinutuzumab (2)

atezolizumab (1)

ro7122290 (1)

tocilizumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

cibisatamab

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Colorectal Cancer Trial in Worldwide (RO7122290, Cibisatamab, Obinutuzumab)

Recruiting

Metastatic Colorectal Cancer

RO7122290
+2 more

Toronto, Ontario, Canada
+15 more

Jan 13, 2023

Colorectal Cancer Trial in Worldwide (Obinutuzumab, Atezolizumab, Cibisatamab)

Active, not recruiting

Colorectal Cancer

Obinutuzumab
+3 more

Los Angeles, California
+12 more

Aug 19, 2022